Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Metabolic Engineering
|
July 20, 2001
Glucose metabolism and regulation of glycolysis in Lactococcus lactis strains with decreased lactate dehydrogenase activity
C Garrigues, N Goupil-Feuillerat, M Cocaign-Bousquet, et al.
Applied and Environmental Microbiology
|
June 29, 2002
Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice
R Oozeer, N Goupil-Feuillerat, C A Alpert, et al.
Alimentary Pharmacology & Therapeutics
|
September 20, 2008
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
A Agrawal, L A Houghton, J Morris, et al.
Neurogastroenterology and Motility
|
January 26, 2012
A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats
S Agostini, M Goubern, V Tondereau, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Metabolic Engineering
|
July 20, 2001
Glucose metabolism and regulation of glycolysis in Lactococcus lactis strains with decreased lactate dehydrogenase activity
C Garrigues, N Goupil-Feuillerat, M Cocaign-Bousquet, et al.
Applied and Environmental Microbiology
|
June 29, 2002
Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice
R Oozeer, N Goupil-Feuillerat, C A Alpert, et al.
Alimentary Pharmacology & Therapeutics
|
September 20, 2008
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
A Agrawal, L A Houghton, J Morris, et al.
Neurogastroenterology and Motility
|
January 26, 2012
A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats
S Agostini, M Goubern, V Tondereau, et al.
Page
of 2